Lipocine Inc. (LPCN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.70
0.10 (2.17%)
At close: Jan 15, 2025, 3:32 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | -2.85M | 500.00K | 16.14M | n/a | 164.99K | 428.03K | n/a | n/a | n/a | n/a | n/a | 7.71M | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.28M | n/a |
Gross Profit | -2.85M | 500.00K | 16.14M | n/a | 164.99K | 428.03K | n/a | n/a | n/a | n/a | n/a | 5.43M | n/a |
Operating Income | -17.93M | -12.12M | 3.15M | -18.00M | -12.90M | -11.33M | -21.22M | -18.46M | -18.38M | -20.48M | -8.76M | 3.88M | -5.16K |
Interest Income | 1.37M | 545.48K | 135.59K | 310.97K | 343.25K | n/a | n/a | n/a | 173.89K | 108.34K | 38.48K | 10.31K | n/a |
Pretax Income | -16.35M | -10.76M | -634.20K | -20.96M | -13.01M | -11.66M | -20.98M | -18.97M | -18.21M | -20.37M | -10.65M | 3.89M | -5.16K |
Net Income | -16.35M | -10.76M | -634.40K | -20.96M | -13.01M | -11.66M | -20.98M | -18.97M | -18.21M | -20.37M | -10.59M | 3.80M | -5.16K |
Selling & General & Admin | 4.90M | 4.06M | 5.33M | 8.25M | 5.60M | 5.29M | 10.21M | 10.38M | 5.80M | 5.00M | 3.64M | 1.55M | 5.00K |
Research & Development | 10.18M | 8.56M | 7.67M | 9.75M | 7.47M | 6.46M | 11.00M | 8.08M | 12.58M | 15.48M | 5.59M | 3.04M | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.08M | 11.80M | 16.64M | 20.65M | 12.83M | 12.09M | 20.98M | 18.97M | 18.38M | 20.48M | 10.68M | 1.55M | 5.16K |
Interest Expense | n/a | 27.10K | 203.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.08M | 11.80M | 16.64M | 20.65M | 12.83M | 12.09M | 20.98M | 18.97M | 18.38M | 20.48M | 10.68M | 3.83M | 5.16K |
Income Tax | 755.00 | 681.00 | 200.00 | 200.00 | 200.00 | 700.00 | 700.00 | 752.00 | 200.00 | 200.00 | 55.05K | 684.00 | n/a |
Shares Outstanding (Basic) | 5.27M | 4.99M | 3.30M | 3.25M | 1.52M | 1.25M | 1.18M | 1.07M | 964.94K | 749.00K | 432.60K | 263.09K | 1.76K |
Shares Outstanding (Diluted) | 5.27M | 5.26M | 5.15M | 3.28M | 1.52M | 1.26M | 1.18M | 1.07M | 968.87K | 750.96K | 433.12K | 262.10K | 1.76K |
EPS (Basic) | -3.14 | -2.15 | -0.19 | -6.46 | -8.54 | -9.35 | -17.79 | -17.66 | -18.79 | -27.13 | -24.45 | 14.50 | -2.93 |
EPS (Diluted) | -3.14 | -2.05 | -0.12 | -6.4 | -8.54 | -9.28 | -17.85 | -17.68 | -18.87 | -27.2 | -24.48 | 14.45 | -2.93 |
EBITDA | -16.32M | -10.72M | -430.53K | -17.99M | -12.65M | -11.31M | -21.19M | -18.94M | -18.36M | -20.47M | -10.62M | -76.65K | -5.16K |
Depreciation & Amortization | 28.66K | 9.45K | 380.00 | 3.55K | 15.44K | 18.59K | 28.37K | 31.96K | 26.72K | 14.62K | 21.77K | 42.57K | n/a |